Frauke Alves

9.2k total citations · 1 hit paper
169 papers, 5.7k citations indexed

About

Frauke Alves is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Frauke Alves has authored 169 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 52 papers in Biomedical Engineering and 39 papers in Oncology. Recurrent topics in Frauke Alves's work include Nanoplatforms for cancer theranostics (30 papers), Advanced X-ray Imaging Techniques (25 papers) and Cancer Research and Treatments (15 papers). Frauke Alves is often cited by papers focused on Nanoplatforms for cancer theranostics (30 papers), Advanced X-ray Imaging Techniques (25 papers) and Cancer Research and Treatments (15 papers). Frauke Alves collaborates with scholars based in Germany, Italy and France. Frauke Alves's co-authors include Wolfgang F. Vogel, Tony Pawson, Gerald Gish, Christian Dullin, Joanna Napp, Marta Zientkowska, Luis A. Pardo, M. Andrea Markus, Attila Aszódi and Walter Stühmer and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Frauke Alves

158 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Discoidin Domain Receptor Tyrosine Kinases Are Activated by Collagen

1997 798 citations Frauke Alves et al. profile →

Peers

Countries citing papers authored by Frauke Alves

Since Specialization

Citations

This map shows the geographic impact of Frauke Alves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frauke Alves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frauke Alves more than expected).

Fields of papers citing papers by Frauke Alves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frauke Alves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frauke Alves. The network helps show where Frauke Alves may publish in the future.

Co-authorship network of co-authors of Frauke Alves

This figure shows the co-authorship network connecting the top 25 collaborators of Frauke Alves. A scholar is included among the top collaborators of Frauke Alves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frauke Alves. Frauke Alves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autonomous bioluminescence emission from transgenic mice 2025 ·Science Advances ·(unknown), Christian Dullin, Heinz Steffens, (unknown), (unknown), Frauke Alves, Carola Gregor	0
2	Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer 2025 ·Vaccines ·Daniele Ferrari, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Luis J. Cruz, Fernando Alberício, François Trottein, Frauke Alves, M. Andrea Markus, (unknown)	2
3	3D correlative light and electron microscopy reveals the uptake and processing of inorganic-organic hybrid nanoparticles into cancer cells 2025 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), David Wild, (unknown), (unknown), Anna M. Steyer, Julian Hennies, Frauke Alves, Claus Feldmann, Andreas Walter	0
4	Label-free quantification of imaging features in the extracellular matrix of left and right-sided colon cancer tissues 2024 ·Scientific Reports ·B Arora, Ajinkya Kulkarni, M. Andrea Markus, Philipp Ströbel, Hanibal Bohnenberger, Frauke Alves, (unknown)	2
5	A Curated Cell Life Imaging Dataset of Immune-enriched Pancreatic Cancer Organoids with Pre-trained AI Models 2024 ·Scientific Data ·Ajinkya Kulkarni, (unknown), (unknown), (unknown), Frauke Alves	5
6	High‐Load Core@Shell Nanocarriers with Irinotecan and 5‐Fluorouracil for Combination Chemotherapy in Colorectal Cancer 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Wiebke Möbius, Tiago De Oliveira, Lena‐Christin Conradi, Frauke Alves, Claus Feldmann	1
7	Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model 2024 ·Frontiers in Oncology ·Joanna Napp, (unknown), (unknown), Kenny Kuchta, Thomas Efferth, Frauke Alves, Volker Ellenrieder, Silke Cameron	0
8	Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling 2024 ·Cancer Letters ·(unknown), Andreas Bosio, Frauke Alves, Philipp Ströbel, Olaf Hardt	16
9	Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC) 2024 ·ACS Omega ·(unknown), (unknown), Daniele Ferrari, (unknown), Míriam Royo, Gerardo Acosta, Luis J. Cruz, Frauke Alves, E Agner, Magne O. Sydnes, Fernando Alberício	1
10	Characterization of transient and progressive pulmonary fibrosis by spatially correlated phase contrast microCT, classical histopathology and atomic force microscopy 2024 ·Computers in Biology and Medicine ·(unknown), (unknown), Elena Longo, Ruth Meyer, (unknown), (unknown), Philipp Nolte, Willi L. Wagner, Mark O. Wielpütz, Dominik Leitz, Julia Duerr, Marcus Mall, Loredana Casalis, Sarah Köster, Frauke Alves, (unknown), Christian Dullin	6
11	Optical clearing: an alternative sample preparation method for propagation based phase contrast μCT 2024 ·Frontiers in Physics ·(unknown), (unknown), (unknown), (unknown), Jeannine Missbach‐Guentner, Elena Longo, (unknown), Hanibal Bohnenberger, Frauke Alves, Christian Dullin	0
12	High‐Load Gemcitabine Inorganic–Organic Hybrid Nanoparticles as an Image‐Guided Tumor‐Selective Drug‐Delivery System to Treat Pancreatic Cancer 2023 ·Advanced Materials ·(unknown), (unknown), (unknown), Christof M. Niemeyer, Joanna Napp, Claus Feldmann, Frauke Alves	20
13	Basal‐like mammary carcinomas stimulate cancer stem cell properties through AXL‐signaling to induce chemotherapy resistance 2023 ·International Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), Olaf Hardt, (unknown), (unknown), Wolfgang Deppert, Florian Wegwitz, Frauke Alves	4
14	ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness 2022 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Claudia Müller, Stefan Kalkhof, (unknown), Henning Urlaub, Frauke Alves, Julia Gallwas, (unknown), Florian Wegwitz	2
15	3D virtual histology of human pancreatic tissue by multiscale phase-contrast X-ray tomography 2020 ·Journal of Synchrotron Radiation ·(unknown), (unknown), (unknown), (unknown), Markus Osterhoff, Frauke Alves, Tim Salditt	33
16	Biofunctionalized Polyelectrolyte Microcapsules Encoded with Fluorescent Semiconductor Nanocrystals for Highly Specific Targeting and Imaging of Cancer Cells 2019 ·Photonics ·(unknown), (unknown), (unknown), (unknown), Frauke Alves, А. В. Караулов, Igor Nabiev, Alyona Sukhanova	9
17	Next-Generation Theranostic Agents Based on Polyelectrolyte Microcapsules Encoded with Semiconductor Nanocrystals: Development and Functional Characterization 2018 ·Nanoscale Research Letters ·(unknown), (unknown), (unknown), Е. В. Коростылев, (unknown), Frauke Alves, Igor Nabiev, Alyona Sukhanova	19
18	Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots 2018 ·Scientific Reports ·(unknown), Julia Bode, Alyona Sukhanova, Svetlana Bozrova, Mara Saccomano, Mišo Mitkovski, (unknown), Anja K. Wege, Walter Stuehmer, Pavel Samokhvalov, Daniel Baty, Patrick Chames, Igor Nabiev, Frauke Alves	32
19	The Heat Shock Protein HSP70 Promotes Mouse NK Cell Activity against Tumors That Express Inducible NKG2D Ligands 2007 ·The Journal of Immunology ·Leslie Elsner, Vijayakumar Muppala, Mathias Gehrmann, Jingky Lozano-Kühne, Dörthe Malzahn, Heike Bickeböller, Edgar Brunner, Marta Zientkowska, Thomas Herrmann, Lutz Walter, Frauke Alves, Gabriele Multhoff, Ralf Dressel	122
20	Dissociation of Angiogenesis and Tumorigenesis in Follistatin- and Activin-Expressing Tumors 2006 ·Cancer Research ·(unknown), Jens Krøll, Frauke Alves, Claudia Prahst, Farahnaz Sananbenesi, Christian Dullin, Sarah Kimmina, David J. Phillips, Hellmut G. Augustin	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact